Abstract
BackgroundThe optimal treatment of nonparasitic liver cysts is still a topic of debate. Only symptomatic cysts are being considered as requiring treatment. Aim of this study is to evaluate our experience with this disease over the past ten years with a structured follow-up program.MethodsFrom January 2000 to August 2010, 56 consecutive patients with nonparasitic liver cysts were treated at our institution. We assessed morbidity, recurrence and complication rates, quality of life as well as pre- and post-operative sonographic status of the cysts and course of clinical symptoms.ResultsIn 84% of the patients surgery was started as a laparoscopic procedure. Conversion rate was 6.4%. Average diameter of deroofed cysts was 12 cm. Overall complication rate was 16% and overall recurrence rate 28.3% (8.7% recurrences at the surgical site, 19.6% new or enlarged cysts). One half of the patients were symptom-free after surgery and the other half had at least one persisting symptom post-operatively. In one half of these patients with persisting symptoms, symptoms were ameliorated by surgery. In the other half of patients the number of symptoms increased after surgery. Two thirds of the overall patients reported their post-operative health as being good or very good.ConclusionsSurgical deroofing is the most effective treatment option for symptomatic liver cysts. Half of our patient population retained at least one symptom from a group of more than ten abdominal symptoms.Only the minority of these cases may be attributed to true recurrence, de-novo cysts or growing pre-existing cysts. The analysis of our cases suggests that the persistent symptoms in our patients may in part be due to the fact that the association between clinical complaints and the liver cysts was not sufficiently established. A more rigid patient selection should be implemented in order to achieve better results from the treatment of cysts. Because even large cysts are frequently asymptomatic, patient selection should not primarily be based on the cyst size only. The decision should be based strictly on the correlation between cyst / cyst location and symptoms / clinical complaints. In our opinion, further diagnostic procedures may be necessary in individual cases to clarify such a correlation.
Highlights
The optimal treatment of nonparasitic liver cysts is still a topic of debate
Four patients had died during follow-up
Our work suggests that un-specific symptoms may have been judged too un-critically as being the cause of clinical complaints and, have been judged to be relevant for the decision making (Table 3)
Summary
The optimal treatment of nonparasitic liver cysts is still a topic of debate. Symptomatic cysts are being considered as requiring treatment. Aim of this study is to evaluate our experience with this disease over the past ten years with a structured follow-up program. Nonparasitic liver cysts occur in up to 5% of the population [1,2]. There are simple (single or multiple) cysts (simple liver cyst, SLC) as opposed to polycystic liver disease (PCLD). There is currently a general agreement that only symptomatic cysts should be treated. 10%-16% of patients with liver cysts develop symptoms at some stage in life [3]. Symptoms develop at an advanced age and are nonspecific. Women are more frequently affected [4,5]. As the recurrence rate of percutaneous drainage alone is up to
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
